With the industry generally supporting recent Food and Drug Administration guidance on medical mobile applications, an HDM blogger warns that the guidance carries some consequences and could unlevel the playing field.
In “Mobile Health Gets Political,” Zachary Landman, M.D., chief medical officer at mobile app developer DoctorBase, worries that large communications companies could benefit at the expense of smaller outfits, hurting competition and innovation. Among other concerns, he writes: “Given the regulatory hurdles for data gathering applications, investments may shift away from startups in this industry. Those who do continue in the regulated industry may be forced to consolidate resources, form partnerships, and lobby for better defined Medicare or payer reimbursement categories for these types of medical technology.”
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access